Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George T Grossberg

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Geriatric Psychiatry|February 12, 2011
Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analysesGustavo Alva, George T Grossberg, Frederick A Schmitt, et al.
CNS Neuroscience & Therapeutics|August 9, 2013
A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementiaMartin R Farlow, George T Grossberg, Carl H Sadowsky, et al.
Expert Opinion on Pharmacotherapy|July 6, 2022
Pharmacotherapy for Alzheimer's disease: what's new on the horizon?Rita Khoury, Amy Gallop, Kelsey Roberts, et al.
Expert Review of Neurotherapeutics|May 24, 2024
The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer's disease: a critical reviewAustin Buck, Kayvon Rezaei, Aman Quazi, et al.
Journal of Geriatric Psychiatry and Neurology|July 5, 2021
Psychosis in Parkinson's Disease: Current Treatment Options and Impact on Patients and CaregiversGilad S Segal, Sophie J Xie, Saif-Ur-Rahman Paracha, et al.
Expert Opinion on Pharmacotherapy|February 22, 2021
AVP-786 as a promising treatment option for Alzheimer's Disease including agitationRita Khoury, Charlotte Marx, Sidney Mirgati, et al.
Current Nutrition Reports|July 19, 2020
Dietary Interventions to Prevent or Delay Alzheimer's Disease: What the Evidence ShowsZachary Bartochowski, Joseph Conway, Yisrael Wallach, et al.
Journal of the American Medical Directors Association|February 7, 2016
The Saint Louis University Mental Status Examination Is Better than the Mini-Mental State Examination to Determine the Cognitive Impairment in Turkish Elderly PeopleDerya Kaya, Ahmet Turan Isik, Cansu Usarel, et al.
Journal of the American Medical Directors Association|June 24, 2014
Cognitive deficit reversal as shown by changes in the Veterans Affairs Saint Louis University Mental Status (SLUMS) examination scores 7.5 years laterDulce M Cruz-Oliver, Theodore K Malmstrom, Michael Roegner, et al.
American Journal of Alzheimer'S Disease and Other Dementias|September 20, 2015
Quality Improvement in Skilled Nursing Facilities for Residents With Alzheimer's DiseaseMartin R Farlow, Soo Borson, Stephen R Connor, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Geriatric Psychiatry|February 12, 2011
Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analysesGustavo Alva, George T Grossberg, Frederick A Schmitt, et al.
CNS Neuroscience & Therapeutics|August 9, 2013
A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementiaMartin R Farlow, George T Grossberg, Carl H Sadowsky, et al.
Expert Opinion on Pharmacotherapy|July 6, 2022
Pharmacotherapy for Alzheimer's disease: what's new on the horizon?Rita Khoury, Amy Gallop, Kelsey Roberts, et al.
Expert Review of Neurotherapeutics|May 24, 2024
The donepezil transdermal system for the treatment of patients with mild, moderate, or severe Alzheimer's disease: a critical reviewAustin Buck, Kayvon Rezaei, Aman Quazi, et al.
Journal of Geriatric Psychiatry and Neurology|July 5, 2021
Psychosis in Parkinson's Disease: Current Treatment Options and Impact on Patients and CaregiversGilad S Segal, Sophie J Xie, Saif-Ur-Rahman Paracha, et al.
Expert Opinion on Pharmacotherapy|February 22, 2021
AVP-786 as a promising treatment option for Alzheimer's Disease including agitationRita Khoury, Charlotte Marx, Sidney Mirgati, et al.
Current Nutrition Reports|July 19, 2020
Dietary Interventions to Prevent or Delay Alzheimer's Disease: What the Evidence ShowsZachary Bartochowski, Joseph Conway, Yisrael Wallach, et al.
Journal of the American Medical Directors Association|February 7, 2016
The Saint Louis University Mental Status Examination Is Better than the Mini-Mental State Examination to Determine the Cognitive Impairment in Turkish Elderly PeopleDerya Kaya, Ahmet Turan Isik, Cansu Usarel, et al.
Journal of the American Medical Directors Association|June 24, 2014
Cognitive deficit reversal as shown by changes in the Veterans Affairs Saint Louis University Mental Status (SLUMS) examination scores 7.5 years laterDulce M Cruz-Oliver, Theodore K Malmstrom, Michael Roegner, et al.
American Journal of Alzheimer'S Disease and Other Dementias|September 20, 2015
Quality Improvement in Skilled Nursing Facilities for Residents With Alzheimer's DiseaseMartin R Farlow, Soo Borson, Stephen R Connor, et al.
Pageof 14